These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 20655737)
1. MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. Xu C; Liu S; Fu H; Li S; Tie Y; Zhu J; Xing R; Jin Y; Sun Z; Zheng X Eur J Cancer; 2010 Oct; 46(15):2828-36. PubMed ID: 20655737 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells. Hu H; Li S; Liu J; Ni B Acta Biochim Biophys Sin (Shanghai); 2012 May; 44(5):424-30. PubMed ID: 22491710 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101 [TBL] [Abstract][Full Text] [Related]
4. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648 [TBL] [Abstract][Full Text] [Related]
5. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L Cancer Res; 2010 Jun; 70(12):5184-93. PubMed ID: 20501828 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. Li Q; Wang G; Shan JL; Yang ZX; Wang HZ; Feng J; Zhen JJ; Chen C; Zhang ZM; Xu W; Luo XZ; Wang D J Gastroenterol Hepatol; 2010 Jan; 25(1):164-71. PubMed ID: 19793168 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference. Xie B; Xing R; Chen P; Gou Y; Li S; Xiao J; Dong J J Surg Res; 2010 Aug; 162(2):231-8. PubMed ID: 19765730 [TBL] [Abstract][Full Text] [Related]
8. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway. Chen C; Chang YC; Liu CL; Liu TP; Chang KJ; Guo IC Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064 [TBL] [Abstract][Full Text] [Related]
9. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. Jiang Y; Xu W; Lu J; He F; Yang X Biochem Biophys Res Commun; 2001 Sep; 286(5):1123-30. PubMed ID: 11527416 [TBL] [Abstract][Full Text] [Related]
10. Reduction of PKC alpha decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma. Wu TT; Hsieh YH; Hsieh YS; Liu JY J Cell Biochem; 2008 Jan; 103(1):9-20. PubMed ID: 17486587 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness. Xu Y; Chen Q; Li W; Su X; Chen T; Liu Y; Zhao Y; Yu C Oncogene; 2010 Jun; 29(23):3386-97. PubMed ID: 20305690 [TBL] [Abstract][Full Text] [Related]
12. Involvement of the Ets-1 gene in overexpression of matrilysin in human hepatocellular carcinoma. Ozaki I; Mizuta T; Zhao G; Yotsumoto H; Hara T; Kajihara S; Hisatomi A; Sakai T; Yamamoto K Cancer Res; 2000 Nov; 60(22):6519-25. PubMed ID: 11103822 [TBL] [Abstract][Full Text] [Related]
13. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition. Park MY; Kim KR; Park HS; Park BH; Choi HN; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS Int J Oncol; 2007 Dec; 31(6):1309-15. PubMed ID: 17982656 [TBL] [Abstract][Full Text] [Related]
14. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283 [TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Murakami Y; Yasuda T; Saigo K; Urashima T; Toyoda H; Okanoue T; Shimotohno K Oncogene; 2006 Apr; 25(17):2537-45. PubMed ID: 16331254 [TBL] [Abstract][Full Text] [Related]
17. In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells. Salvi A; Arici B; Portolani N; Giulini SM; De Petro G; Barlati S Int J Oncol; 2007 Aug; 31(2):451-60. PubMed ID: 17611703 [TBL] [Abstract][Full Text] [Related]
18. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080 [TBL] [Abstract][Full Text] [Related]
19. [Effect of brain-derived neurotrophic factor on in vitro metastasis of hepatocellular carcinoma cell line HepG2]. Xiao ZY; Wang YD; Chen XP Ai Zheng; 2006 Mar; 25(3):287-91. PubMed ID: 16536980 [TBL] [Abstract][Full Text] [Related]
20. Expression and possible role of ets-1 in hepatocellular carcinoma. Ito Y; Miyoshi E; Takeda T; Sakon M; Noda K; Tsujimoto M; Monden M; Taniguchi N; Matsuura N Am J Clin Pathol; 2000 Nov; 114(5):719-25. PubMed ID: 11068545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]